Vaxart (VXRT) Receivables (2010 - 2026)
Vaxart (VXRT) posted Receivables of $47.01 million for Q2 2026, up 14.4% from $41.1 million a year earlier but down 18.3% from the prior quarter.
Powered by 
Analysis
Vaxart (VXRT) Receivables (2010 - 2026) Analysis & Trends
At the end of FY2025, Vaxart's Receivables came in at $51.4 million, up 329.4% from FY2024.
- Annual Receivables shows a five-year compound annual growth rate of 173.8% (FY2020 to FY2025).
- In prior years, Vaxart's Receivables was $11.97 million in FY2024 (+297.9%), $3.01 million in FY2023, $100,000 in FY2022 (+40.8%) and $71,000 in FY2021 (-78.7%).
- Quarterly Receivables has run from a low of $29,000 in Q2 2023 to a high of $85.95 million in Q3 2025 over five years.
- On a year-over-year basis, Receivables has increased in each of the last three quarters, with growth averaging 404.4% over the last six quarters.
- The strongest year-over-year quarter for Receivables in the past five years was Q3 2024, with growth of 767.0%; the weakest was Q1 2022, with a decline of 91.3%.
- According to Business Quant data, Receivables for the three prior quarters was $57.57 million (Q1 2026), $51.4 million (Q4 2025) and $85.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Vaxart | 115.76 Mn | 51.76 Mn | - | 47.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.01 Mn |
| Mar 31, 2026 | 57.57 Mn |
| Dec 31, 2025 | 51.40 Mn |
| Sep 30, 2025 | 85.95 Mn |
| Jun 30, 2025 | 41.10 Mn |
| Mar 31, 2025 | 16.12 Mn |
| Dec 31, 2024 | 11.96 Mn |
| Sep 30, 2024 | 3.68 Mn |
| Jun 30, 2024 | 4.78 Mn |
| Mar 31, 2024 | 556,000.00 |
| Dec 31, 2023 | 3.01 Mn |
| Sep 30, 2023 | 424,000.00 |
| Jun 30, 2023 | 29,000.00 |
| Mar 31, 2023 | 264,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Mar 31, 2022 | 81,000.00 |
| Dec 31, 2021 | 71,000.00 |
| Sep 30, 2021 | 190,000.00 |
| Jun 30, 2021 | 107,000.00 |
| Mar 31, 2021 | 932,000.00 |
API Access
Vaxart Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=VXRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "VXRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=VXRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();